California Independent Diagnostic Testing Facility and Owner Agree to Voluntary Exclusion

On October 24, 2017, Prohealth Neurodiagnostic, Inc., an independent diagnostic testing facility in Van Nuys, California, and Arsen Oganesyan, its owner (collectively, "Prohealth"), agreed to be excluded for a period of five years under 42 U.S.C. § 1320a-7(b)(7). OIG's investigation revealed that Prohealth submitted claims for nerve conduction studies that are considered screening exams and not covered by Medicare, in violation of a Local Coverage Determination governing the medical necessity of such studies. OIG's Office of Audit Services and Office of Counsel to the Inspector General, represented by Senior Counsels Geoffrey Hymans and Kenneth Kraft, collaborated to achieve this resolution.

Share